JPWO2022044573A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022044573A5
JPWO2022044573A5 JP2022545513A JP2022545513A JPWO2022044573A5 JP WO2022044573 A5 JPWO2022044573 A5 JP WO2022044573A5 JP 2022545513 A JP2022545513 A JP 2022545513A JP 2022545513 A JP2022545513 A JP 2022545513A JP WO2022044573 A5 JPWO2022044573 A5 JP WO2022044573A5
Authority
JP
Japan
Prior art keywords
seq
light chain
antigen
antibody
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022545513A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022044573A1 (https=
JP7773154B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/026053 external-priority patent/WO2022044573A1/ja
Publication of JPWO2022044573A1 publication Critical patent/JPWO2022044573A1/ja
Publication of JPWO2022044573A5 publication Critical patent/JPWO2022044573A5/ja
Application granted granted Critical
Publication of JP7773154B2 publication Critical patent/JP7773154B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022545513A 2020-08-26 2021-07-09 コロナウイルススパイク蛋白に対するヒト抗体またはその抗原結合断片 Active JP7773154B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2020143055 2020-08-26
JP2020143055 2020-08-26
JP2021054387 2021-03-26
JP2021054387 2021-03-26
PCT/JP2021/026053 WO2022044573A1 (ja) 2020-08-26 2021-07-09 コロナウイルススパイク蛋白に対するヒト抗体またはその抗原結合断片

Publications (3)

Publication Number Publication Date
JPWO2022044573A1 JPWO2022044573A1 (https=) 2022-03-03
JPWO2022044573A5 true JPWO2022044573A5 (https=) 2023-06-20
JP7773154B2 JP7773154B2 (ja) 2025-11-19

Family

ID=80353115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022545513A Active JP7773154B2 (ja) 2020-08-26 2021-07-09 コロナウイルススパイク蛋白に対するヒト抗体またはその抗原結合断片

Country Status (4)

Country Link
US (1) US20230312689A1 (https=)
EP (1) EP4206224A4 (https=)
JP (1) JP7773154B2 (https=)
WO (1) WO2022044573A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115073594A (zh) * 2022-06-08 2022-09-20 四川大学华西医院 一种抗新冠病毒SARS-CoV-2突变株表面S2蛋白的单链抗体、制备方法及其应用
WO2024053719A1 (ja) 2022-09-08 2024-03-14 国立大学法人熊本大学 コロナウイルス変異株に対するヒト抗体またはその抗原結合断片
CN118406139A (zh) * 2022-09-30 2024-07-30 郴州市第一人民医院 一种抗新型冠状病毒SARS-CoV-2的广谱中和抗体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK1399484T3 (da) 2001-06-28 2010-11-08 Domantis Ltd Dobbelt-specifik ligand og anvendelse af denne
AU2003244817B2 (en) 2002-06-28 2010-08-26 Domantis Limited Antigen-binding immunoglobulin single variable domains and dual-specific constructs
EP1578801A2 (en) 2002-12-27 2005-09-28 Domantis Limited Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
DE602004017726D1 (de) 2003-06-30 2008-12-24 Domantis Ltd Pegylierte Single-domain-antikörper (dAb)
CA2595780A1 (en) 2005-02-08 2006-08-17 Shibo Jiang Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
MX2008014710A (es) 2006-05-19 2009-02-12 Amgen Inc Anticuerpos para coronavirus del sars.
KR20250107297A (ko) * 2020-04-02 2025-07-11 리제너론 파아마슈티컬스, 인크. 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편
CN111647076B (zh) * 2020-04-27 2021-02-26 南京医科大学 抗新型冠状病毒SARS-Cov-2的中和性单域抗体及其应用
CN111718411B (zh) * 2020-06-19 2022-03-08 武汉生物制品研究所有限责任公司 一种抗SARS-CoV-2的单克隆抗体1F2
CN112521494B (zh) * 2020-06-19 2021-06-25 武汉生物制品研究所有限责任公司 一种抗SARS-CoV-2的单克隆抗体2B11
CN111909261B (zh) * 2020-08-19 2022-10-04 重庆医科大学 新冠病毒rbd特异性单克隆抗体和应用
WO2022155324A1 (en) * 2021-01-15 2022-07-21 The Rockefeller University Neutralizing anti-sars-cov-2 antibodies

Similar Documents

Publication Publication Date Title
JP2024109678A5 (https=)
RU2009129403A (ru) Антитела, нейтрализующие цитомегаловирус человека, и их применение
JP2021521843A5 (https=)
CN112135626A (zh) 抗tigit抗体及其用途
CN112409488B (zh) 针对多种冠状病毒的单克隆抗体及应用
JP2018035138A5 (https=)
JP2010516229A5 (https=)
JP2018527952A5 (https=)
JPWO2022044573A5 (https=)
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2017514461A5 (https=)
JP2019522961A5 (https=)
JP2025501775A5 (https=)
JP2022529154A5 (https=)
JP2022533538A5 (https=)
JP2023540526A5 (https=)
JP2024541680A5 (https=)
JP2020522280A5 (https=)
JP2017523805A5 (https=)
RU2017104638A (ru) Нейтрализующие антитела к вирусу гриппа B и пути их применения
JP2023509373A5 (https=)
JP2022517216A5 (https=)
JP2019518473A5 (https=)
IL277899B2 (en) Methods and preparations for treating yellow fever
TW202309076A (zh) 用於治療α-突觸核蛋白病之抗體